Basic information
- Name:
Benzenemethanol, 3-hydroxy-α-[(methylamino)methyl]-,hydrochloride (1:1), (aR)-
- Superlist Name:
- Phenylephrine hydrochloride
- CAS No.:
61-76-7
- Molecular Structure:
![Molecular Structure of 61-76-7 (Benzenemethanol, 3-hydroxy-α-[(methylamino)methyl]-,hydrochloride (1:1), (aR)-)](http://www.lookchem.com/300w/2010/0623/61-76-7.jpg)
- Formula:
- C9H14ClNO2
- Molecular Weight:
- 203.6
- Synonyms:
- L(-)-Phenylephrine hydrochloride;(R)-(-)-1-(3-Hydroxyphenyl)-2-methylaminoethanol hydrochloride;3-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol;
- EINECS:
- 200-517-3
- Melting Point:
- 143-145 °C(lit.)
- Boiling Point:
- 341.1 °C at 760 mmHg
- Flash Point:
- 163.4 °C
- Appearance:
- white to almost white crystalline powder
- Hazard Symbols:
Xn- Risk Codes:
- 22-36/37/38
- Safety Description:
- 26-36-37/39 Details
- Transport Information:
- UN 3249
Famous Chemical Enterprises
-
Livzon -
Total -
Shell -
Dupont -
Exxonmobil -
Akzonobel -
Basf -
Bayer -
BP
Please post your buying leads,so that our qualified suppliers will soon
contact you!
*Required Fields
Consensus Reports
Specification
This chemical is called Phenylephrine hydrochloride, and its systematic name is Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, hydrochloride (1:1), (alphaR)-. With the CAS registry number of 61-76-7, its classification codes are Adrenergic [ophthalmic]; Diagnostic aid [radiopaque medium, cholecystographic]; Drug / Therapeutic Agent; Human Data; Mutation data; Reproductive Effect; Tumor data. Additionally, this chemical is soluble in water and ethanol, insoluble in chloroform and ethyl ether.
Other characteristics of the Phenylephrine hydrochloride can be summarised as followings: (1)ACD/LogP: -0.03; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -3.05; (4)ACD/LogD (pH 7.4): -1.92; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 1; (8)ACD/KOC (pH 7.4): 1; (9)#H bond acceptors: 3; (10)#H bond donors: 3; (11)#Freely Rotating Bonds: 5; (12)Polar Surface Area: 18.46 Å2; (13)Flash Point: 163.4 °C; (14)Enthalpy of Vaporization: 61.71 kJ/mol; (15)Boiling Point: 341.1 °C at 760 mmHg; (16)Vapour Pressure: 3.18E-05 mmHg at 25°C.
Uses of this chemical: The Phenylephrine hydrochloride is an alpha-adrenergic agonist served as a mydriatic, nasal decongestant, and cardiotonic agent. It's used as drenergic drugs, having contraction effect on blood vessels of local body. It's also used for swelling and inflammation of nasal congestion, Extending anesthesia time.
When you are using this chemical, please be cautious about it as the following: This chemical is irritating to eyes, respiratory system and skin. You should wear suitable protective clothing if you use it. In case of contacting with eyes, rinse immediately with plenty of water and seek medical advice.
You can still convert the following datas into molecular structure:
1.SMILES: [Cl-].O[C@H](c1cc(O)ccc1)C[NH2+]C
2.InChI: InChI=1/C9H13NO2.ClH/c1-10-6-9(12)7-3-2-4-8(11)5-7;/h2-5,9-12H,6H2,1H3;1H/t9-;/m0./s1
3.InChIKey:OCYSGIYOVXAGKQ-FVGYRXGTBL
The toxicity data is as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| dog | LDLo | intraperitoneal | 16mg/kg (16mg/kg) | International Journal of Neuropharmacology. Vol. 4, Pg. 219, 1965. | |
| man | TDLo | ocular | 120mg/kg (120mg/kg) | BRAIN AND COVERINGS: "CHANGES IN CIRCULATION (HEMORRHAGE, THROMBOSIS, ETC.)" BEHAVIORAL: MUSCLE WEAKNESS | Southern Medical Journal. Vol. 86, Pg. 1064, 1993. |
| mouse | LD50 | intraperitoneal | 89mg/kg (89mg/kg) | Toxicology and Applied Pharmacology. Vol. 28, Pg. 227, 1974. | |
| mouse | LD50 | intravenous | 1120ug/kg (1.12mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES LUNGS, THORAX, OR RESPIRATION: DYSPNEA | European Journal of Pharmacology. Vol. 9, Pg. 289, 1970. |
| mouse | LD50 | oral | 120mg/kg (120mg/kg) | International Journal of Neuropharmacology. Vol. 4, Pg. 219, 1965. | |
| mouse | LD50 | subcutaneous | 22mg/kg (22mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 86, Pg. 284, 1946. | |
| rabbit | LD50 | intramuscular | 7200ug/kg (7.2mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 86, Pg. 284, 1946. | |
| rabbit | LD50 | intravenous | 500ug/kg (0.5mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 86, Pg. 284, 1946. | |
| rabbit | LD50 | subcutaneous | 22mg/kg (22mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 86, Pg. 284, 1946. | |
| rat | LD50 | intraperitoneal | 17mg/kg (17mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 86, Pg. 284, 1946. | |
| rat | LD50 | intravenous | 440ug/kg (0.44mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Journal of Pharmacology and Experimental Therapeutics. Vol. 113, Pg. 341, 1955. |
| rat | LD50 | oral | 350mg/kg (350mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 180, Pg. 155, 1969. | |
| rat | LD50 | subcutaneous | 27mg/kg (27mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 86, Pg. 284, 1946. |

